SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U201. A total of 33 filers reported holding SYNTHETIC BIOLOGICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $25,000 | -24.2% | 116,430 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $33,000 | -65.6% | 116,430 | -66.7% | 0.00% | +100.0% |
Q4 2021 | $96,000 | +81.1% | 349,290 | +200.0% | 0.00% | -50.0% |
Q3 2021 | $53,000 | -24.3% | 116,430 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $70,000 | -89.3% | 116,430 | -87.9% | 0.00% | -92.0% |
Q1 2021 | $655,000 | – | 960,680 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Virtu Financial LLC | 306,479 | $87,000 | 0.01% |
1620 INVESTMENT ADVISORS, INC. | 15,000 | $4,000 | 0.00% |
Landmark Financial Advisors, LLC | 24,200 | $6,000 | 0.00% |
MSD Partners, L.P. | 116,430 | $33,000 | 0.00% |
IFP Advisors, Inc | 17,650 | $58,000 | 0.00% |
Jacobi Capital Management LLC | 18,500 | $5,000 | 0.00% |
Focused Wealth Management, Inc | 500 | $0 | 0.00% |
JANE STREET GROUP, LLC | 281,700 | $80,000 | 0.00% |
UBS Group AG | 79,851 | $23,000 | 0.00% |
BNP PARIBAS FINANCIAL MARKETS | 1 | $0 | 0.00% |